lobbying_activities
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
344 rows where filing_period = "third_quarter", filing_year = 2021 and issue_code = "MED" sorted by filing_year descending
This data as json, CSV (advanced)
Suggested facets: filing_type, income_amount, is_termination, received_date (date)
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year ▲ | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2674805 | BALLARD PARTNERS c9a323fd-d81d-4ff8-a00e-3d0650937414 | 3T | BALLARD PARTNERS | 401104288 | ORIGIN LOGISTICS, LLC | 2021 | third_quarter | MED | Issues related to diagnostic testing for COVID-19. | 60000 | 0 | 1 | 2021-09-15T17:15:15.373000-04:00 | ||
| 2675557 | WINNING STRATEGIES WASHINGTON 833661bd-94cc-4e9f-bd9a-f5a8be2eee27 | 3T | WINNING STRATEGIES WASHINGTON | 50796 | PHLOW CORPORATION | 2021 | third_quarter | MED | Domestic manufacturing of essential generic medicines; supply chain disruptions and shortages of foreign-manufactured medicines | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 1 | 2021-09-29T17:39:10.693000-04:00 | |
| 2675587 | THE CONSILIO GROUP 999d73e1-cc52-4c27-b74b-4ec448901043 | Q3 | THE CONSILIO GROUP | 400374717 | DETECTACHEM | 2021 | third_quarter | MED | Chemical detection test for COVID-19 | Air Force, Dept of,Defense, Dept of (DOD),Drug Enforcement Administration (DEA),Education, Dept of,Federal Bureau of Investigation (FBI),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Navy, Dept of,SENATE,Transportation Security Administration (TSA),White House Office | 16500 | 0 | 0 | 2021-09-30T12:58:23.870000-04:00 | |
| 2675655 | FRANCIS EDWARD & CRONIN, INC. c3263745-22ed-485e-9c2e-14e6e42a156c | Q3 | FRANCIS EDWARD & CRONIN, INC. | 311314 | CURE ALZHEIMER'S FUND | 2021 | third_quarter | MED | Issues and legislation related to Alzheimer's disease research | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE | 20000 | 0 | 0 | 2021-10-01T08:59:50.457000-04:00 | |
| 2675656 | FRANCIS EDWARD & CRONIN, INC. 70a6c1fa-3ec5-4185-bbea-e37dabd05f8b | Q3 | FRANCIS EDWARD & CRONIN, INC. | 311314 | PATH DECISION SUPPORT SOFTWARE, LLC | 2021 | third_quarter | MED | Issues and legislation related to diabetes treatment and diagnosis | HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Natl Science Foundation (NSF),SENATE,Veterans Affairs, Dept of (VA) | 0 | 0 | 2021-10-01T09:03:51.083000-04:00 | ||
| 2675675 | RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) bba68268-0f76-48b2-bf53-ab212f79d17a | Q3 | RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) | 400361684 | PPLA | 2021 | third_quarter | MED | Pharmaceutical Labeling | Food & Drug Administration (FDA) | 18700 | 0 | 0 | 2021-10-01T10:24:59.180000-04:00 | |
| 2675918 | MARSHALL BRACHMAN 4c5b1c55-b8c0-48a9-87a8-a71f9ed9b00d | Q3 | MARSHALL BRACHMAN | 6848 | BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM | 2021 | third_quarter | MED | support funding for medical research programs | HOUSE OF REPRESENTATIVES,SENATE | 33000 | 0 | 0 | 2021-10-02T15:30:25.937000-04:00 | |
| 2675960 | RAY C CULVER III c156ad59-b7c2-4a3e-a731-91a9fb1bd594 | Q3 | RAY C CULVER III | 11468 | ARKANSAS CHILDREN'S HOSPITAL | 2021 | third_quarter | MED | FY2022 Agricultural Appropriations bill funding for USDA ARS human nutrition research centers | HOUSE OF REPRESENTATIVES,SENATE | 5000 | 0 | 0 | 2021-10-03T01:48:38.950000-04:00 | |
| 2676067 | AMERICAN COLLEGE OF CLINICAL PHARMACY c75f644f-7937-43e1-a672-d9019562331a | Q3 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 57258 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 2021 | third_quarter | MED | Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE | 144981 | 0 | 0 | 2021-10-04T10:02:17.787000-04:00 | |
| 2676139 | THE HARRIS FIRM cf4fa00c-fa8a-4c60-bde9-dc736db38e14 | Q3 | THE HARRIS FIRM | 68376 | HOLISTIC INDUSTRIES INC. | 2021 | third_quarter | MED | Issues pertaining to cannabis CSA scheduling. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2021-10-04T12:10:52.667000-04:00 | |
| 2676193 | MAGILL ASSOCIATES, LLC c654b1f4-e206-4cbf-b22b-a619b35f3d14 | Q3 | MAGILL ASSOCIATES, LLC | 401103511 | THE LIVINGSTON GROUP ON BEHALF OF INNOVATIVE VACCINE TECHNOLOGIES | 2021 | third_quarter | MED | FY'22 defense appropriations bill for the development of a synthetic vaccine | Army, Dept of (Other),Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2021-10-04T14:52:14.787000-04:00 | |
| 2676396 | ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) 8dd62ee0-f712-43eb-a87d-aa36d3f2c6b5 | Q3 | ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) | 1466 | ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) | 2021 | third_quarter | MED | AACC joined with other healthcare groups in writing to the Centers for Medicare and Medicaid Services requesting the agency issue a State Medicaid Director Letter that instructs State Medicaid programs to recognize and process claims submitted with Proprietary Laboratory Analysis (PLA) codes established by the American Medical Associations Current Procedural Terminology (CPT) Editorial Panel. AACC joined with other healthcare groups in writing to the Centers for Medicare and Medicaid Services to express concerns regarding coding changes included in both the 2021 National Correct Coding Initiative (NCCI) Policy Manual for Medicare Services and the 2021 NCCI Policy Manual for Medicaid Services, which took effect January 1, 2021. | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 90000 | 0 | 0 | 2021-10-05T12:23:59.750000-04:00 | |
| 2676418 | BEN BARNES GROUP LP 52fb3470-0877-4938-bc77-e764d5adb1d6 | Q3 | BEN BARNES GROUP LP | 5415 | ENVIGO RMS LLC | 2021 | third_quarter | MED | Medical/Disease Research | HOUSE OF REPRESENTATIVES,SENATE | 15000 | 0 | 0 | 2021-10-05T14:23:10.680000-04:00 | |
| 2676439 | BEN BARNES GROUP LP 331aecad-1805-4926-82f9-06de314978f4 | Q3 | BEN BARNES GROUP LP | 5415 | HUNTSMAN CORPORATION | 2021 | third_quarter | MED | CMS Medicare | SENATE | 18750 | 0 | 0 | 2021-10-05T14:48:18.557000-04:00 | |
| 2676978 | RYAN COSTELLO STRATEGIES 9266fa94-b01b-4c2d-aa2c-114b71092cee | Q3 | RYAN COSTELLO STRATEGIES | 401105569 | CARDIOL THERAPEUTICS | 2021 | third_quarter | MED | No specific lobbying issues this quarter. | HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 40000 | 0 | 0 | 2021-10-07T13:17:37.797000-04:00 | |
| 2676982 | WAKE FOREST UNIVERSITY HEALTH SCIENCES bc1ff1e2-5c48-47b5-99bb-239b3e5ac423 | Q3 | WAKE FOREST UNIVERSITY HEALTH SCIENCES | 6781 | WAKE FOREST UNIVERSITY HEALTH SCIENCES | 2021 | third_quarter | MED | Proposed provisions in the draft Build Back Better bill regarding mental health and maternity expanded coverage;340 (b) program guidelines; HRSA community project funding; "Research Investment to Spark the Economy" (RISE) Act; "US Citizenship Act of 2021"; | Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 150000 | 0 | 0 | 2021-10-07T13:26:47.373000-04:00 | |
| 2676998 | REPUBLIC CONSULTING, LLC 3625bf38-b6f0-40b5-b6b7-00866b8bb143 | Q3 | REPUBLIC CONSULTING, LLC | 401016871 | IQVIA | 2021 | third_quarter | MED | Monitored health Data Policy. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2021-10-07T13:59:53.117000-04:00 | |
| 2677322 | EFB ADVOCACY, LLC b2b630de-7786-4567-95e5-cc47dec820e6 | Q3 | EFB ADVOCACY, LLC | 401104430 | UNITED FOR MEDICAL RESEARCH | 2021 | third_quarter | MED | Funding Issues Related to the National Institutes of Health | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2021-10-08T11:49:40.977000-04:00 | |
| 2677420 | MARSHFIELD CLINIC HEALTH SYSTEM cd8610df-7996-4b81-949d-488eb06caa81 | Q3 | MARSHFIELD CLINIC HEALTH SYSTEM | 57830 | MARSHFIELD CLINIC HEALTH SYSTEM | 2021 | third_quarter | MED | COVID-19, agricultural occupational health, NIOSH | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 70000 | 0 | 0 | 2021-10-08T14:58:30.160000-04:00 | |
| 2677940 | IMPACT MANAGEMENT GROUP 3bc80c27-3f77-49a2-aeb1-715a8fad9da5 | Q3 | IMPACT MANAGEMENT GROUP | 401104137 | ARKANSAS RESEARCH ALLIANCE | 2021 | third_quarter | MED | On behalf of client support continued and future funding for clinical research programs in Arkansas | HOUSE OF REPRESENTATIVES,SENATE | 9000 | 0 | 0 | 2021-10-11T15:03:13.240000-04:00 | |
| 2678205 | THE CJR GROUP, INC. e56b7c53-4429-4fe2-94ca-582e68c962ef | Q3 | THE CJR GROUP, INC. | 288293 | UNIVERSITY HOSPITALS HEALTH SYSTEM | 2021 | third_quarter | MED | Issues related to COVID-19 and funding for hospitals | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2021-10-12T09:12:13.797000-04:00 | |
| 2678772 | ALEXANDER, BOROVICKA & O'SHEA GOVERNMENT SOLUTIONS (FKA ALEXANDER & BOROVICKA GO 76d518ce-ec1f-4b22-ba84-410808485e03 | Q3 | ALEXANDER, BOROVICKA & O'SHEA GOVERNMENT SOLUTIONS (FKA ALEXANDER & BOROVICKA GO | 40025213 | VOLAN TECHNOLOGY INC. | 2021 | third_quarter | MED | Discuss COVID-19 technology and detection for indoor spaces and uses. | SENATE | 0 | 0 | 2021-10-12T16:05:05.423000-04:00 | ||
| 2678785 | STANFORD UNIVERSITY 0049d40e-d6de-4b83-b42b-731412f5c7a6 | Q3 | STANFORD UNIVERSITY | 36492 | STANFORD UNIVERSITY | 2021 | third_quarter | MED | H.R.708; S168 Temporary Reciprocity to Ensure Access to Treatment Act H.R. 2256, S. 834 Resident Physician Shortage Reduction Act of 2021 Title VII HRSA Health Professions Programs | Energy, Dept of,HOUSE OF REPRESENTATIVES,SENATE | 90000 | 0 | 0 | 2021-10-12T16:06:06.760000-04:00 | |
| 2678834 | MCDERMOTT+ LLC 936f6802-fe4a-4fc0-983b-706b2ee99c14 | Q3 | MCDERMOTT+ LLC | 401103287 | COALITION FOR 21ST CENTURY MEDICINE | 2021 | third_quarter | MED | Issues concerning regulation of laboratory-developed tests. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE | 40000 | 0 | 0 | 2021-10-12T17:04:17.710000-04:00 | |
| 2678851 | WASHINGTON STATE UNIVERSITY 711d9f3f-964b-45d9-bef7-84de0c542660 | Q3 | WASHINGTON STATE UNIVERSITY | 40657 | WASHINGTON STATE UNIVERSITY | 2021 | third_quarter | MED | Disease Surveilance, CLIA, Public Health | Agriculture, Dept of (USDA),Defense, Dept of (DOD),Education, Dept of,Energy, Dept of,Environmental Protection Agency (EPA),Federal Communications Commission (FCC),Federal Emergency Management Agency (FEMA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA),Transportation, Dept of (DOT),White House Office | 72053 | 0 | 0 | 2021-10-12T17:21:20.233000-04:00 | |
| 2678996 | COMPASS MANAGEMENT PARTNERS, INC. c4d75172-0734-4b8a-b9e7-110a3e09c931 | Q3 | COMPASS MANAGEMENT PARTNERS, INC. | 401105171 | THE LIVING LEGACY FOUNDATION OF MARYLAND | 2021 | third_quarter | MED | Regulations impacting accountability requirements at organ procurement organizations; organ donation matters | 0 | 0 | 2021-10-13T10:16:06.507000-04:00 | |||
| 2679061 | UNIVERSITY OF MARYLAND, BALTIMORE (UMB) 91ecd51b-b909-4a12-84bc-21a4a792125f | Q3 | UNIVERSITY OF MARYLAND, BALTIMORE (UMB) | 401103161 | UNIVERSITY OF MARYLAND, BALTIMORE (UMB) | 2021 | third_quarter | MED | H.R. 3684 - Infrastructure Investment & Jobs Act | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2021-10-13T10:47:22.387000-04:00 | |
| 2679104 | COVINGTON & BURLING LLP a11ad9d4-3d9a-48d5-a9bf-727ea4247f36 | Q3 | COVINGTON & BURLING LLP | 11195 | SL 2T, LLC ("SMARTLABS") | 2021 | third_quarter | MED | Education and support for policies and funding to advance turnkey, co-located, on-demand pharma grade research laboratory environments. | HOUSE OF REPRESENTATIVES,SENATE | 90000 | 0 | 0 | 2021-10-13T11:11:37.840000-04:00 | |
| 2679118 | COVINGTON & BURLING LLP fd354bc2-88c1-4823-ae97-86843c3591df | 3T | COVINGTON & BURLING LLP | 11195 | ZYMERGEN INC. | 2021 | third_quarter | MED | Enhanced investment in biomanufacturing; investment in workforce development, infrastructure, and R&D for synthetic biology; shoring up manufacturing supply chains for critical pharmaceutical ingredients; supporting government investment in mRNA-based technologies | 20000 | 0 | 1 | 2021-10-13T11:16:41.003000-04:00 | ||
| 2679214 | ISEMAN & ASSOCIATES LLC 2528ad86-fe3b-4a85-8fde-6c9077a3a12c | Q3 | ISEMAN & ASSOCIATES LLC | 401103582 | TICHENOR VENTURES, LLC | 2021 | third_quarter | MED | Monitoring biotech legislation | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2021-10-13T12:03:07.827000-04:00 | |
| 2679272 | HELIX, INC. 449eb306-2c9c-4e91-bd65-3c3adbc033b7 | Q3 | HELIX, INC. | 401106164 | HELIX, INC. | 2021 | third_quarter | MED | genomic research and testing, COVID-19 testing and research | Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 36000 | 0 | 0 | 2021-10-13T13:23:24.617000-04:00 | |
| 2679524 | GOVERNMENT COUNSEL, LLC d15fcb36-a883-4e71-953a-9f4e847e2668 | Q3 | GOVERNMENT COUNSEL, LLC | 401105070 | HOOPER,LUNDY& BOOKMAN, PC (OBO ROCHE DIAGNOSTICS) | 2021 | third_quarter | MED | Verifying Accurate Leading-edge IVCT Development (VALID) Act | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2021-10-13T15:57:40.093000-04:00 | |
| 2679533 | AMERICAN ACADEMY OF PHYSICAL MEDICINE AND REHABILITATION e6ae46d6-ef1b-4e33-93f5-03b96b75a8a3 | Q3 | AMERICAN ACADEMY OF PHYSICAL MEDICINE AND REHABILITATION | 400864533 | AMERICAN ACADEMY OF PHYSICAL MEDICINE AND REHABILITATION | 2021 | third_quarter | MED | Rehabilitation research funding | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 10000 | 0 | 0 | 2021-10-13T15:57:41.443000-04:00 | |
| 2679617 | AMERICAN ASSOCIATION FOR CANCER RESEARCH 835b16d2-8e04-483c-a6da-e2b2b2f6702f | Q3 | AMERICAN ASSOCIATION FOR CANCER RESEARCH | 400601833 | AMERICAN ASSOCIATION FOR CANCER RESEARCH | 2021 | third_quarter | MED | Cancer research Oncology product review at the FDA Pediatric research and cancer care Clinical trials | HOUSE OF REPRESENTATIVES,SENATE | 100000 | 0 | 0 | 2021-10-13T17:07:04.520000-04:00 | |
| 2679749 | MANATOS & MANATOS e668b733-c79c-4a36-aad0-30850d3bbfc5 | Q3 | MANATOS & MANATOS | 23634 | BARBARA ANN KARMANOS CANCER INSTITUTE | 2021 | third_quarter | MED | PPS-exemption | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2021-10-14T08:14:43.323000-04:00 | ||
| 2679762 | MOLNLYCKE HEALTH CARE US, LLC d24a8690-db19-4b53-9087-5987200ebf94 | Q3 | MOLNLYCKE HEALTH CARE US, LLC | 401104898 | MOLNLYCKE HEALTH CARE US, LLC | 2021 | third_quarter | MED | Report language to support reduction of pressure injuries, falls, and infections | HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2021-10-14T08:40:48.297000-04:00 | |
| 2680133 | MCHUGH LEMAY ASSOC., LLC e375e9c5-f855-4974-b57c-334eaed40680 | Q3 | MCHUGH LEMAY ASSOC., LLC | 401105253 | CLARK STREET ASSOCIATES LLC ON BEHALF OF QORVO | 2021 | third_quarter | MED | Issues related to COVID testing - no specific legislation. | Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2021-10-14T11:55:10.173000-04:00 | |
| 2680754 | BOLD STRATEGIES, LLC 881fef2a-8b15-4f3c-950d-6151ead7c121 | Q3 | BOLD STRATEGIES, LLC | 401104653 | PENNINGTON BIOMEDICAL RESEARCH CENTER | 2021 | third_quarter | MED | Obesity and COVID research. FY22 appropriations. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2021-10-14T17:06:01.650000-04:00 | |
| 2680760 | BOLD STRATEGIES, LLC d3635fe4-ffec-4374-b898-82b8d103a565 | Q3 | BOLD STRATEGIES, LLC | 401104653 | COUHIG PARTNERS LLC | 2021 | third_quarter | MED | COVID related and other medical research. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2021-10-14T17:08:03.357000-04:00 | |
| 2680811 | NATURAL RESOURCE RESULTS LLC d4319957-3f32-41b2-8b2e-074e098b001d | Q3 | NATURAL RESOURCE RESULTS LLC | 321555 | SHINE MEDICAL TECHNOLOGIES | 2021 | third_quarter | MED | Support funding at NNSA for Moly-99 domestic production facility construction. | SENATE | 30000 | 0 | 0 | 2021-10-14T17:39:18.520000-04:00 | |
| 2680881 | FOLEY & LARDNER LLP 750e1dbc-cfac-4289-b968-f84b7348aa43 | Q3 | FOLEY & LARDNER LLP | 15042 | CARDIAC RMS | 2021 | third_quarter | MED | Remote Cardiac Monitoring | HOUSE OF REPRESENTATIVES,SENATE | 6000 | 0 | 0 | 2021-10-14T20:32:45.297000-04:00 | |
| 2681150 | SQUIRE PATTON BOGGS aba9ade5-2191-4cce-bff1-e35954a581ac | Q3 | SQUIRE PATTON BOGGS | 30906 | LA MAESTRA FOUNDATION ON BEHALF OF LA MAESTRA FAMILY CLINIC, INC. | 2021 | third_quarter | MED | Funding support for federally qualified health centers; reauthorization of programs | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2021-10-15T10:19:08.817000-04:00 | |
| 2681213 | TODD STRATEGY GROUP 8599bacd-2037-4e35-be20-34f9cb548eff | Q3 | TODD STRATEGY GROUP | 401103321 | ORGANIZE.ORG | 2021 | third_quarter | MED | Organ procurement policy. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2021-10-15T10:41:27.233000-04:00 | |
| 2681257 | UNIVERSITY OF IOWA e54be645-16c7-4735-89a7-a846cbb561ec | Q3 | UNIVERSITY OF IOWA | 49191 | UNIVERSITY OF IOWA | 2021 | third_quarter | MED | Support for robust funding for federal agencies that fund medical and disease research Support for increased federal funding for research and response efforts in response to COVID-19 | Agriculture, Dept of (USDA),Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Oceanic & Atmospheric Administration (NOAA),SENATE | 60000 | 0 | 0 | 2021-10-15T10:46:32.843000-04:00 | |
| 2681286 | DREXEL UNIVERSITY 581a445e-814f-4b2f-8dba-cdb00e15b0c6 | Q3 | DREXEL UNIVERSITY | 40032273 | DREXEL UNIVERSITY | 2021 | third_quarter | MED | Research, education and other matters related to higher ed. | HOUSE OF REPRESENTATIVES,SENATE | 81000 | 0 | 0 | 2021-10-15T10:52:40.443000-04:00 | |
| 2681484 | CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 169df1f1-0e58-410d-bdb2-bbe86c75c22a | Q3 | CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER | 312496 | CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER | 2021 | third_quarter | MED | CHGME, NIH, PACT ACT, Genomics, Cures 2.0 | Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office | 31485 | 0 | 0 | 2021-10-15T12:07:40.287000-04:00 | |
| 2681551 | KOUNTOUPES DENHAM CARR & REID, LLC d4cb41e2-3517-44e1-892a-d28c62b74b84 | Q3 | KOUNTOUPES DENHAM CARR & REID, LLC | 320918 | ICI (INFRARED CAMERAS, INC.) | 2021 | third_quarter | MED | Issues relating to bio-risk detection and mitigation using infrared thermal imaging technology. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2021-10-15T12:35:58.210000-04:00 | |
| 2681666 | INFECTIOUS DISEASES SOCIETY OF AMERICA ccf32174-7e65-4286-bf94-74a5218a8526 | Q3 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 54836 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 2021 | third_quarter | MED | Antimicrobial resistance research, infectious disease product R&D regulatory science, unnecessary regulatory burdens placed on medical research; laboratory developed tests; comparative effectiveness research; support for evidence-based decision making; point-of-care diagnostic tests; and organ transplant policies to allow HIV+ to HIV+ organ transplants, Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR Act-S. 2076/H.R. 3932), Verifying Accurate Leading Edge IVCT Development (S. 2209/HR. 4128) | Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 77000 | 0 | 0 | 2021-10-15T13:56:21.877000-04:00 | |
| 2681964 | GREENBERG TRAURIG, LLP ac9135ec-f406-4f71-9208-dc0fc7d181df | Q3 | GREENBERG TRAURIG, LLP | 16896 | LIFE MOLECULAR IMAGING (F/K/A PIRAMAL IMAGING LIMITED) | 2021 | third_quarter | MED | Administrative and legislative monitoring and outreach related to Alzheimers Disease research funding. Administrative and legislative monitoring and outreach related to pass-through payments for clinical trials. Draft Revision, Medicare Diagnostic Radiopharmaceutical Payment Equity Act. H.R. 4479, Facilitating Innovative Nuclear Diagnostics Act of 2021. S. 2609, Facilitating Innovative Nuclear Diagnostics Act of 2021. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES | 20000 | 0 | 0 | 2021-10-15T15:44:26.697000-04:00 | |
| 2682164 | BLUEBIRD STRATEGIES 167cb505-6134-4582-a965-74f5bc997ca6 | Q3 | BLUEBIRD STRATEGIES | 401105447 | MYRIAD GENETICS, INC. | 2021 | third_quarter | MED | Legislation to regulate clinical labs under CLIA and FDA. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2021-10-15T17:08:12.020000-04:00 | |
| 2682174 | BLUEBIRD STRATEGIES de8b1d9f-f542-4d90-b759-dc5c69169465 | Q3 | BLUEBIRD STRATEGIES | 401105447 | GLOBAL DOWN SYNDROME FOUNDATION | 2021 | third_quarter | MED | Funding for Immune Facility at Crnic Institute FY22 LHHS Appropriations. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 0 | 0 | 2021-10-15T17:12:14.217000-04:00 | ||
| 2682203 | BLUEBIRD STRATEGIES 90cb8cc6-3108-47a4-ad13-17affb0751d2 | Q3 | BLUEBIRD STRATEGIES | 401105447 | MYOTONIC | 2021 | third_quarter | MED | Increasing funding for Myotonic Dystrophy research. Fiscal Year 2020 defense appropriations legislation. Peer Review Medical Research Program and Congressional Directed Medical Research Program. Myotonic Dystrophy resolution. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 0 | 0 | 2021-10-15T17:26:21.050000-04:00 | ||
| 2682275 | FORBES-TATE 15ae2d3b-9eae-49e4-80f8-4826b8253b3a | Q3 | FORBES-TATE | 400976792 | AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION | 2021 | third_quarter | MED | Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2021-10-15T19:27:41.393000-04:00 | |
| 2682339 | TIBER CREEK GROUP c87c8610-beb4-4dc3-b4d8-1bf23846edff | Q3 | TIBER CREEK GROUP | 20744 | JAZZ PHARMACEUTICALS | 2021 | third_quarter | MED | Issues related to the FDA and S. 3032 - the FDA STATES Act (115th Congress), and Health and Human Services pertaining to CBD policies. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2021-10-15T21:03:59.633000-04:00 | |
| 2682396 | FORBES-TATE b2da4e83-96a3-4b6e-b938-85bef883026f | Q3 | FORBES-TATE | 400976792 | COALITION FOR CANNABIS POLICY, EDUCATION, AND REGULATION | 2021 | third_quarter | MED | Issues pertaining to government-wide federal regulation of cannabis. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2021-10-15T22:24:10.047000-04:00 | |
| 2682559 | MARSHALL & POPP, LLC 3be130e4-ba5b-4e81-bfaa-e63b0107e3c2 | Q3 | MARSHALL & POPP, LLC | 401105121 | BUTTERFLY NETWORK, INC. | 2021 | third_quarter | MED | Issues related to medical device manufacturing / insurance / technology. | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2021-10-16T08:58:29.997000-04:00 | |
| 2682621 | FORBES-TATE 3ddc2746-c2e6-424a-9558-378fe35b0d22 | Q3 | FORBES-TATE | 400976792 | CSL BEHRING | 2021 | third_quarter | MED | Issues related to COVID-19 response efforts. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2021-10-16T09:59:50.880000-04:00 | |
| 2682651 | IMPACT HEALTH POLICY PARTNERS 1e9293a0-5592-4e33-98ab-46321d38772d | Q3 | IMPACT HEALTH POLICY PARTNERS | 401104696 | ABBOTT LABORATORIES | 2021 | third_quarter | MED | Issues related to coverage and reimbursement for durable medical equipment, medical devices, diagnostics and nutrition. | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2021-10-16T10:37:03.620000-04:00 | |
| 2682653 | IMPACT HEALTH POLICY PARTNERS ea39f97b-9339-4ea0-be98-d51a99e11d72 | Q3 | IMPACT HEALTH POLICY PARTNERS | 401104696 | CHILDREN'S HOSPITAL COLORADO | 2021 | third_quarter | MED | Issues related to pediatric research and children's hospital graduate medical education. | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2021-10-16T10:41:04.650000-04:00 | |
| 2682662 | K&L GATES, LLP bddae1a9-a4cd-47a1-a69a-c850ad47bacb | Q3 | K&L GATES, LLP | 32098 | CHEMBIO DIAGNOSTICS, INC. | 2021 | third_quarter | MED | Issues related to disease diagnostics testing and manufacturing - no specific legislation. | SENATE | 10000 | 0 | 0 | 2021-10-16T10:48:08.647000-04:00 | |
| 2682665 | IMPACT HEALTH POLICY PARTNERS 3ba170e3-5c06-43a5-89d2-a388bf2938e9 | Q3 | IMPACT HEALTH POLICY PARTNERS | 401104696 | HACKENSACK MERIDIAN HEALTH | 2021 | third_quarter | MED | Issues related to research funding, NIH and other matters. | HOUSE OF REPRESENTATIVES,SENATE,White House Office | 30000 | 0 | 0 | 2021-10-16T10:52:09.607000-04:00 | |
| 2683064 | MS. TAMI WAHL 3aaf88d3-23aa-4a50-9337-56a91b656765 | Q3 | MS. TAMI WAHL | 401104405 | ASSOCIATION OF CANNABIS SPECIALISTS | 2021 | third_quarter | MED | Ensuring a medical cannabis paradigm is included in any comprehensive federal reform legislation and that such paradigm is subject to appropriate standards to allow best possible patient outcomes. | SENATE | 0 | 0 | 2021-10-16T16:33:03.790000-04:00 | ||
| 2683146 | CAPITOL COUNSEL LLC e2e6dda6-3191-48fd-95c7-d993dd4cd8ec | Q3 | CAPITOL COUNSEL LLC | 313715 | BLUE EARTH DIAGNOSTICS, INC. | 2021 | third_quarter | MED | To gain support for adequate Medicare reimbursement for diagnostic radiopharmaceuticals; Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021. | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2021-10-16T19:10:25.087000-04:00 | |
| 2683159 | CAPITOL COUNSEL LLC 504e615d-c9be-44d7-b953-aa6a7638a7d3 | Q3 | CAPITOL COUNSEL LLC | 313715 | EMD SERONO, INC. | 2021 | third_quarter | MED | Monitoring and engaging on health policy proposals coming before the House of Representatives and the Administration pertaining to the availability and pricing of prescription drugs. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2021-10-16T19:53:30.727000-04:00 | |
| 2683168 | CAPITOL COUNSEL LLC 7b01fc93-7f26-41e4-b0d7-d4ee8213467b | Q3 | CAPITOL COUNSEL LLC | 313715 | MASSACHUSETTS BIOTECHNOLOGY COUNCIL | 2021 | third_quarter | MED | Monitor health and tax legislation pertaining to the biotechnology industry. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2021-10-16T20:07:33.077000-04:00 | |
| 2683302 | FORBES-TATE 258482f6-41fe-4c07-9fbe-2f954047101b | Q3 | FORBES-TATE | 400976792 | LUNDBECK LLC | 2021 | third_quarter | MED | Issues related to Mental health and Alzheimer's disease research; Issues related to the Food and Drug Administration; Issues related to protected class drug. Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instructions to Committees. | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2021-10-17T13:38:24.463000-04:00 | |
| 2683312 | HAWLEY LLC e8964242-8f13-43a8-8302-d8a827fc828b | Q3 | HAWLEY LLC | 401105460 | MLA ASSOCIATES ON BEHALF OF CLARK STREET ASSOCIATES LLC ON BEHALF OF QORVO | 2021 | third_quarter | MED | Issues related to pathogen testing for COVID 19 and other diseases. | Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2021-10-17T13:44:26.823000-04:00 | |
| 2683335 | FORBES-TATE dafa60cc-9e76-4de9-8ef9-c2b5cebab4ae | 3T | FORBES-TATE | 400976792 | NASH ALLIANCE COALITION | 2021 | third_quarter | MED | Issues related to the NASH Care Act - preventing, diagnosing, and treating nonalcoholic steatohepatitis. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 1 | 2021-10-17T14:15:33.863000-04:00 | ||
| 2683433 | LYMPHOMA RESEARCH FOUNDATION 1d7e5a8f-fb45-43b8-bd27-e4703d14438c | Q3 | LYMPHOMA RESEARCH FOUNDATION | 300696 | LYMPHOMA RESEARCH FOUNDATION | 2021 | third_quarter | MED | Advanced Research Projects Agency for Health (ARPA-H) | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2021-10-17T15:36:55.333000-04:00 | ||
| 2683441 | TURNER & GOSS LLP 0d67d2d8-ba36-4f13-aeb7-e805133b3b8b | Q3 | TURNER & GOSS LLP | 316310 | LYMPHOMA RESEARCH FOUNDATION | 2021 | third_quarter | MED | Advice on the structure and financing of the Advanced Research Projects Agency for Health (ARPA-H). | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2021-10-17T15:47:59.277000-04:00 | ||
| 2683445 | TURNER & GOSS LLP f2897215-36f7-41ae-911b-04271855a011 | Q3 | TURNER & GOSS LLP | 316310 | CANCER LEADERSHIP COUNCIL | 2021 | third_quarter | MED | Provide advice on the organizational structure and mission of the Advanced Research Project Agency for Health (ARPA-H). | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2021-10-17T15:59:01.517000-04:00 | ||
| 2683728 | MICHIGAN TECHNOLOGICAL UNIVERSITY 2c1ec3af-e3c7-4b00-b730-d6e38ed61f04 | Q3 | MICHIGAN TECHNOLOGICAL UNIVERSITY | 25181 | MICHIGAN TECHNOLOGICAL UNIVERSITY | 2021 | third_quarter | MED | Discussed issues of interest related to higher education for the COVID-19 pandemic. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2021-10-18T08:19:09.477000-04:00 | |
| 2683796 | SAM ACTION, INC. 06069724-cb8d-48a8-8d48-2594b9f09fa4 | Q3 | SAM ACTION, INC. | 401104337 | SAM ACTION, INC. | 2021 | third_quarter | MED | H.R. 3797, Medical Marijuana Research Act, S. 2032, Cannabidiol and Marijuana Research Expansion Act, to lower the barriers of researching marijuana. | Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Institutes of Health (NIH),Office of Natl Drug Control Policy (NDCP),SENATE,Small Business Administration (SBA),White House Office | 10000 | 0 | 0 | 2021-10-18T09:03:22.190000-04:00 | |
| 2684057 | DQB INTERNATIONAL 4af058ac-e66c-4b83-a55a-3c0f35572f99 | Q3 | DQB INTERNATIONAL | 291834 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 2021 | third_quarter | MED | FY 2022 Labor, HHS Appropriations Bill | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2021-10-18T10:09:26.767000-04:00 | ||
| 2684205 | WATKINS & EAGER PLLC d6c2ecbd-899a-44c0-b533-5799a49582e5 | Q3 | WATKINS & EAGER PLLC | 401104403 | NATIONAL FRAGILE X FOUNDATION | 2021 | third_quarter | MED | Encourage Members to act favorably on legislation that would benefit those impacted by Fragile X & their constituents. | HOUSE OF REPRESENTATIVES,SENATE | 15000 | 0 | 0 | 2021-10-18T10:47:06-04:00 | |
| 2684275 | THE PRENDA GROUP LLC 5f497fe4-e697-4ccb-b3df-9e5b054d91be | Q3 | THE PRENDA GROUP LLC | 401104543 | UV-CONCEPTS | 2021 | third_quarter | MED | Emergency response to COVID-19 Pandemic. Assistance to Hospitals / Veterans Administration Facilities / First Responders / Medical facilities etc. for patients, visitors, and healthcare workers. ULTRAVIOLET LIGHT ENCLOSURE TECHNOLOGY FOR BROAD APPLICATIONS IN HEALTHCARE AND NON-HEALTHCARE SECTORS. Monitoring COVID-19 Stimulus Packages and appropriations. Coronavirus Response and Relief HR 3684 Monitoring Infrastructure. Veterans Appropriations HR 4355. HR 4550 Transportation Appropriations | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2021-10-18T10:57:50-04:00 | |
| 2684352 | SQUIRE PATTON BOGGS 7f606d7c-7fe1-493b-ab3f-2c94eb7a1f9c | Q3 | SQUIRE PATTON BOGGS | 30906 | ALLIANCE FOR BIOSECURITY | 2021 | third_quarter | MED | Preparedness and response as it relates to Biosecurity. | Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 100000 | 0 | 0 | 2021-10-18T11:17:43-04:00 | |
| 2684600 | FORBES-TATE 401211ab-d31e-42f4-8767-4d2d7bc92f9e | Q3 | FORBES-TATE | 400976792 | AMGEN USA, INC. | 2021 | third_quarter | MED | Issues related to Biosimilars. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2021-10-18T11:54:44.293000-04:00 | |
| 2684768 | SQUIRE PATTON BOGGS 7e1a46e9-4165-4fd6-9843-aba2c4047686 | Q3 | SQUIRE PATTON BOGGS | 30906 | IMPACT JOURNALS, LLC | 2021 | third_quarter | MED | National Library of Medicine indexing matters. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2021-10-18T12:19:31.320000-04:00 | |
| 2684821 | FORBES-TATE 644c826f-f452-4042-8235-dde0167ed442 | Q3 | FORBES-TATE | 400976792 | CALIFORNIA LIFE SCIENCES ASSOCIATION | 2021 | third_quarter | MED | Issues related to the life sciences industry; Issues related to drug pricing and international reference pricing. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2021-10-18T12:26:40.670000-04:00 | |
| 2684984 | MEEKS, BUTERA & ISRAEL PLLC 9b28a40c-07a7-44a6-bc4f-dddc2598875d | 3T | MEEKS, BUTERA & ISRAEL PLLC | 401105818 | SOCIETY FOR BRAIN MAPPING & THERAPEUTICS (SBMT) | 2021 | third_quarter | MED | Brain technology and medical research issues and programs. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 1 | 2021-10-18T13:14:25.343000-04:00 | |
| 2685034 | AMERICAN SOCIETY OF ADDICTION MEDICINE d1c2b6be-38ca-4cf5-813e-0fb1763e8153 | Q3 | AMERICAN SOCIETY OF ADDICTION MEDICINE | 401104864 | AMERICAN SOCIETY OF ADDICTION MEDICINE | 2021 | third_quarter | MED | Advocated for Increased appropriations for HRSAs Substance Use Disorder Treatment and Recovery Loan Repayment Program. This program provides student loan repayment for addiction treatment professionals who commit to working in underserved or high-risk communities. Advocated for increased appropriations for HRSAs Addiction Medicine Fellowship Program. This Program provides grants to institutions with training opportunities for fellows in addiction medicine and addiction psychiatry who have demonstrated interest in providing addiction treatment in underserved communities Advocated for increased appropriations for HRSAs Integrated Substance Use Disorder Training Program. This program provides grants to expand the number of nurse practitioners, physician assistants, psychologists, and social workers trained to provide addiction and mental health services in underserved community-based settings that integrate primary care, mental health, and addiction services. Advocated for increased appropriations for federal initiatives that lead to a more diverse addiction treatment workforce, such as scholarships and loan repayment targeting underrepresented minority addiction medicine professionals, including SAMHSAs Minority Fellowship Program. Advocated for the alignment of coverage and payment policies in Medicare and Medicaid with evidence-based and nationally recognized addiction treatment and placement criteria and standards (e.g., The ASAM Criteria). This would include permanent modification to the Institutions for Mental Diseases (IMD) exclusion to allow federal Medicaid funds to serve individuals with SUDs in those residential and inpatient settings that are able to demonstrate that patient assessments, clinical services, level-of-care and length-of-stay recommendations are consistent with The ASAM Criteria and that evidence based medication management using Food and Drug Administration (FDA)-approved medications are available to patients in such settings Advocated for regulatory/sub-regulatory/application guidan… | Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA) | 70000 | 0 | 0 | 2021-10-18T13:28:40.217000-04:00 | |
| 2685417 | STRATEGIC MARKETING INNOVATIONS a600c859-61cf-4a8a-8167-8d303589d103 | Q3 | STRATEGIC MARKETING INNOVATIONS | 60550 | IGM BIOSCIENCES, INC. | 2021 | third_quarter | MED | Antibody therapy for COVID-19 | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2021-10-18T14:35:10.333000-04:00 | |
| 2685583 | THE LIVINGSTON GROUP, LLC f6eb3d3d-7c61-4951-9825-c974f42d40a1 | Q3 | THE LIVINGSTON GROUP, LLC | 49635 | INNOVATIVE VACCINE TECHNOLOGIES | 2021 | third_quarter | MED | H.R.4432 S.___ FY 2022 Defense Appropriations Bill FY 2022 appropriations for the development of a synthetic vaccine | Army, Dept of (Other),Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2021-10-18T14:44:35.573000-04:00 | |
| 2685700 | SQUIRE PATTON BOGGS ff2a9ffd-a011-4222-87c3-ee50401e824c | Q3 | SQUIRE PATTON BOGGS | 30906 | NATIONAL CANNABIS ROUNDTABLE | 2021 | third_quarter | MED | Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use. | HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2021-10-18T14:54:59.027000-04:00 | |
| 2686006 | UNIVERSITY OF ROCHESTER 65b87269-ad3f-4b29-ab7a-2551586f1404 | Q3 | UNIVERSITY OF ROCHESTER | 301937 | UNIVERSITY OF ROCHESTER | 2021 | third_quarter | MED | P.L. 114-255 - 21st Century Cures Act | HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2021-10-18T15:26:07.690000-04:00 | |
| 2686410 | SUSAN B ANTHONY LIST aeae88ed-97c3-4d77-9625-a2d2fed5ecb5 | Q3 | SUSAN B ANTHONY LIST | 400935704 | SUSAN B ANTHONY LIST | 2021 | third_quarter | MED | H.R. 554, S. 78 Support and Value Moms and Babies Act; Maternal mortality; Bioethics | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 230000 | 0 | 0 | 2021-10-18T16:13:33.260000-04:00 | |
| 2686426 | WINNING STRATEGIES WASHINGTON d8dcfd5f-85c1-429e-a733-e31662103005 | Q3 | WINNING STRATEGIES WASHINGTON | 50796 | DIABETES PATIENT ADVOCACY COALITION | 2021 | third_quarter | MED | Issues related to treatment of diabetes and support for diabetes patients | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2021-10-18T16:14:34.797000-04:00 | ||
| 2686528 | SMITHS GROUP SERVICES CORPORATION 4fef0021-a697-4f89-bed3-58762fb26533 | Q3 | SMITHS GROUP SERVICES CORPORATION | 290137 | SMITHS GROUP SERVICES CORPORATION | 2021 | third_quarter | MED | Policies and issues related to medical device technology, including: patient infusion therapy, Medicare reimbursement for opioid alternative treatments, federal COVID response, and medical supply chain shortages; H.R.748, CARES Act (P.L.116-136); S.987, CARA 3.0 Act of 2021; S.586/H.R.3259, NOPAIN Act. | Army, Dept of (Other),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Energy, Dept of,Environmental Protection Agency (EPA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Navy, Dept of,SENATE,Transportation Security Administration (TSA),U.S. Customs & Border Protection,White House Office | 250000 | 0 | 0 | 2021-10-18T16:27:59.477000-04:00 | |
| 2686622 | SIDLEY AUSTIN LLP 42e0a72a-7f54-4ac1-bdd2-9086261228b0 | Q3 | SIDLEY AUSTIN LLP | 35230 | CORD BLOOD ASSOCIATION | 2021 | third_quarter | MED | Legislative and Federal agency activities related to the Stem Cell Therapeutic and Research Reauthorization Act of 2015. | Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),White House Office | 20000 | 0 | 0 | 2021-10-18T16:43:22.260000-04:00 | |
| 2686661 | WINNING STRATEGIES WASHINGTON c3643eaf-80f8-4b5f-979d-a16ba9f6479c | Q3 | WINNING STRATEGIES WASHINGTON | 50796 | I AM ALS | 2021 | third_quarter | MED | Funding for ALS research in annual Defense and Labor-HHS-Education Appropriations bills | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 0 | 0 | 2021-10-18T16:50:31.563000-04:00 | ||
| 2687174 | BROWNSTEIN HYATT FARBER SCHRECK, LLP aba36892-d5a6-448b-9e44-eb45aa4159cf | Q3 | BROWNSTEIN HYATT FARBER SCHRECK, LLP | 7257 | ANTHEM, INC. | 2021 | third_quarter | MED | Issues related to the individual marketplace Health insurance tax and general tax issues Part D | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2021-10-18T20:37:36.590000-04:00 | |
| 2687285 | KNIGHT CAPITOL CONSULTANTS 60b001f2-d0e0-4948-8e1e-76d1da4a3272 | Q3 | KNIGHT CAPITOL CONSULTANTS | 40036301 | PERSPECTUM | 2021 | third_quarter | MED | Food and Drug Administration regulation of medical devices, including Emergency Use Authorizations for critical products during the COVID-19 crisis. | Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 40000 | 0 | 0 | 2021-10-18T21:36:01.343000-04:00 | |
| 2687802 | OKLAHOMA STATE UNIVERSITY 1e4f2176-5656-42f9-9c11-773c6416c9e3 | Q3 | OKLAHOMA STATE UNIVERSITY | 30165 | OKLAHOMA STATE UNIVERSITY | 2021 | third_quarter | MED | Graduate Medical Education funding; Teaching Health Center GME reauthorization and funding; indigenous health center; other extraneous issues as they may arise | HOUSE OF REPRESENTATIVES,Natl Science Foundation (NSF),SENATE | 40000 | 0 | 0 | 2021-10-19T05:27:59.210000-04:00 | |
| 2687839 | VAN SCOYOC ASSOCIATES 802de3ba-7dda-48cf-8033-d0ae68e9f818 | Q3 | VAN SCOYOC ASSOCIATES | 39837 | ARUP LABORATORIES, INC. | 2021 | third_quarter | MED | H.R.44128/S.2209, Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021, Diagnostic Lab Testing Laboratory Testing related issues Monitor the following: American Jobs Plan Highly skilled visa related issues CURES 2.0, Diagnostic Lab Testing issues Build Back Better Act/Monitor H.R.3684, Infrastructure Investment and Jobs Act | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2021-10-19T06:13:08.630000-04:00 | |
| 2687854 | VAN SCOYOC ASSOCIATES b8f2ae53-f0a8-40fa-8060-0101aaa783e6 | Q3 | VAN SCOYOC ASSOCIATES | 39837 | MEDICAL COLLEGE OF WISCONSIN | 2021 | third_quarter | MED | H.R.4432, Department of Defense Appropriations Act, FY2022, Healthcare research and development related issues H.R.4355/S.2604, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, FY2022, Healthcare research and development related issues Healthcare research and development related issues, as follows: H.R.4505, Commerce, Justice, Science, and Related Agencies Appropriations Act, FY2022 H.R.4502, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2022 H.R.4550, Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, FY2022 Build Back Better Act, Endowment Tax issues | SENATE | 30000 | 0 | 0 | 2021-10-19T06:22:11.410000-04:00 | |
| 2687940 | VAN SCOYOC ASSOCIATES efa803da-a28e-445c-b165-3a240559f6b6 | 3T | VAN SCOYOC ASSOCIATES | 39837 | HUMANIGEN, INC. | 2021 | third_quarter | MED | Therapeutics manufacturing, review and authorization issues Supply chain and National Stockpile preparedness related issues H.R.4502, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2022 Monitor implementation of Public Law 117-2, American Rescue Plan Act of 2021 | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 1 | 2021-10-19T07:44:37.567000-04:00 | |
| 2688085 | CAPITOL DECISIONS, INC. 7155a246-1500-4c4b-b29f-689f0f4554d9 | Q3 | CAPITOL DECISIONS, INC. | 55165 | VAN SCOYOC ASSOCIATES (MEDICAL UNIVERSITY HOSPITAL AUTHORITY) | 2021 | third_quarter | MED | Monitor the following: Medical research and development related issues National Institutes of Health, and various institutes and bureaus thereof Health Resources Services Administration | 0 | 0 | 2021-10-19T08:49:14.733000-04:00 | |||
| 2688396 | HOOPER, LUNDY & BOOKMAN, P.C. 0971f0e6-2ac3-47e9-950d-04fc3556219b | Q3 | HOOPER, LUNDY & BOOKMAN, P.C. | 401020884 | ROCHE DIAGNOSTICS CORPORATION | 2021 | third_quarter | MED | The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021 (HR 4128/S 2209). | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2021-10-19T09:37:24.560000-04:00 | |
| 2688460 | BOSE PUBLIC AFFAIRS GROUP 0a6ec724-1623-4a34-bdd6-da299f973238 | Q3 | BOSE PUBLIC AFFAIRS GROUP | 297294 | AMERICAN ACADEMY OF ANESTHESIOLOGIST ASSISTANTS | 2021 | third_quarter | MED | issues related to licensure | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) | 10000 | 0 | 0 | 2021-10-19T09:42:40.670000-04:00 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE lobbying_activities (
id INTEGER PRIMARY KEY,
filing_uuid TEXT NOT NULL,
filing_type TEXT NOT NULL,
registrant_name TEXT NOT NULL,
registrant_id INTEGER,
client_name TEXT NOT NULL,
filing_year INTEGER NOT NULL,
filing_period TEXT NOT NULL,
issue_code TEXT,
specific_issues TEXT,
government_entities TEXT,
income_amount INTEGER,
expense_amount INTEGER,
is_no_activity INTEGER DEFAULT 0,
is_termination INTEGER DEFAULT 0,
received_date TEXT,
CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
REFERENCES lobbying_filings_raw(filing_uuid)
);
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);